Carotid Body Tumor - radiological imaging and genetic assessment

Pol Przegl Chir. 2020 Nov 6;92(6):39-44. doi: 10.5604/01.3001.0014.4872.

Abstract

Carotid Body Tumor i.e. Paraganglioma is a challenging entity from the point of multidisciplinary diagnosis. The main treatment option i.e. surgery yields intraoperative risk,related to cranial nerve palsy and vascular morbidity.Bifurcation of Common Carotid Artery especially at the Carotid Body is the place where Head and Neck Paraganglioma is most frequently seen i.e. 60% of incidence [19]. Indeed, the knowledge of genetic germline SDH mutations, which cause deregulation of hypoxia-induced factors yields better understanding of the tumor nature. It is recommended to conduct selective neck dissection in regions IIA, IIB, III to exlude malignant transformation and metastasis, due to malignant potential of Carotid Body Tumors, especially in case of SDHB mutation. SDHD mutation is the main cause of hereditary HNPGLs. Computed tomography (CT), magnetic resonance imaging (MRI) and angiography yield thorough assessment of paraganglioma extension. In large size tumors, embolization of supplying artery under guidance of angiography may be considered. In case of Carotid Body Tumor, differential diagnosis should include: carotid artery aneurysm, lymphadenopathy, Schwannoma of the hypoglossal nerve or acessory thyroid gland.

Keywords: Angiography; Carotid Body Tumor; Computed Tomography; Germline Mutations.; Magnetic Resonance; Paraganglioma.

Publication types

  • Review

MeSH terms

  • Carotid Body Tumor / diagnostic imaging*
  • Carotid Body Tumor / genetics*
  • Carotid Body Tumor / pathology
  • Female
  • Head and Neck Neoplasms / diagnostic imaging
  • Head and Neck Neoplasms / genetics
  • Humans
  • Male
  • Neoplasm Staging
  • Paraganglioma / diagnostic imaging*
  • Paraganglioma / genetics*
  • Paraganglioma / pathology